Macrophages in neovascular age-related macular degeneration: Friends or foes?

Eye

Volumn 23, Issue 4, 2009, Pages 747-755

  Skeie, J M ^a,b   Mullins, R F ^a,c  

^a UNIVERSITY OF IOWA   (United States)

^b IA United States   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Angiogenesis; Animal model; Choroid; Inflammation; Macrophage; Macular degeneration

Indexed keywords

ANTIINFLAMMATORY AGENT; CLODRONIC ACID; TRIAMCINOLONE;

BIOLOGICAL MODEL; EYE PROTECTION; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LASER; LOW LEVEL LASER THERAPY; MACROPHAGE FUNCTION; NONHUMAN; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SUBRETINAL NEOVASCULARIZATION;

ANIMALS; CHOROID; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGES; MACULAR DEGENERATION; MICE;

EID: 65349167290     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.206     Document Type: Review

References (85)

1. Klein R, Klein B, Cruickshanks K. The prevalence of age-related maculopathy by geographic region and ethnicity. Prog Retin Eye Res 1999; 18: 371-389.
2. Buch H, Vinding T, Nielsen N. Prevalence and causes of visual impairment according to World Health Organization and United States criteria in an aged, urban Scandinavian population: the Copenhagen City Eye Study. Ophthalmology 2001; 108: 2347-2357.
3. Smith W, Assink J, Klein R, Mitchell P, Klaver C, Klein B et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology 2001; 108: 697-704.
4. Friedman D, O'Colmain B, Munoz B, Tomany S, McCarty C, de Jong P et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004; 122: 564-572.
5. VanNewkirk M, Nanjan M, Wang J, Mitchell P, Taylor H, McCarty C. The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology 2000; 107: 1593-1600.
6. McMenamin P. The distribution of immune cells in the uveal tract of the normal eye. Eye 1997; 11: 183-193.
7. Blumenkranz M, Russell S, Robey M, Kott-Blumenkranz R, Penneys N. Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology 1986; 93: 552-558.
8. Shankar A, Mitchell P, Rochtchina E, Tan J, Wang JJ. Association between circulating white blood cell count and long-term incidence of age-related macular degeneration. Am J Epidemiol 2007; 165(4): 375-382.
9. Cousins S, Espinosa-Heidmann D, Csaky K. Monocyte activation in patients with age-related macular degeneration: a biomarker of risk for choroidal neovascularization? Arch Ophthalmol 2004; 122: 1013-1018.
10. Seddon J, Gensler G, Milton R, Klein M, Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA 2004; 291: 704-710.
11. Seddon JM, George S, Rosner B, Rifai N. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch Ophthalmol 2005; 123(6): 774-782.
12. Ranson NT, Danis RP, Ciulla TA, Pratt L. Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration. Br J Ophthalmol 2002; 86(5): 527-529.
13. Kaiser PK. Verteporfin therapy in combination with triamcinolone: published studies investigating a potential synergistic effect. Curr Med Res Opin 2005; 21(5): 705-713.
14. Ciulla TA, Criswell MH, Danis RP, Fronheiser M, Yuan P, Cox TA et al. Choroidal neovascular membrane inhibition in a laser treated rat model with intraocular sustained release triamcinolone acetonide microimplants. Br J Ophthalmol 2003; 87(8): 1032-1037.
15. Haddad S, Chen CA, Santangelo SL, Seddon JM. The genetics of age-related macular degeneration: a review of progress to date. Surv Ophthalmol 2006; 51(4): 316-363.
16. Mullins RF. Genetic insights into the pathobiology of age-related macular degeneration. Int Ophthalmol Clin 2007; 47: 1-14.
17. Scholl H, Fleckenstein M, Charbel Issa P, Keilhauer C, Holz F, Weber B. An update on the genetics of age-related macular degeneration. Mol Vis 2007; 13: 196-205.
18. Tuo J, Smith BC, Bojanowski CM, Meleth AD, Gery I, Csaky KG et al. The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J 2004; 18(11): 1297-1299.
19. Goverdhan S, Mullins R, Howell W, Osmond C, Hodgkins P, Self J et al. Association of HLA class I and class II polymorphisms with age-related macular degeneration. Invest Ophthalmol Vis Sci 2005; 46(5): 1726-1734.
20. Klein R, Zeiss C, Chew E, Tsai J, Sackler R, Haynes C et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308: 385-389.
21. Edwards A, Ritter R, Abel K, Manning A, Panhuysen C, Farrer L. Complement factor H polymorphism and agerelated macular degeneration. Science 2005; 308: 421-424.
22. Haines J, Hauser M, Schmidt S, Scott W, Olson L, Gallins P et al. Complement factor H variant increases the risk of agerelated macular degeneration. Science 2005; 308: 419-421.
23. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 2006; 38(4): 458-462.
24. Bressler S, Maguire G, Bressler N, Fine S. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. Arch Ophthalmol 1990; 108: 1442-1447.
25. Pauleikhoff D, Barondes M, Minassian D, Chisholm I, Bird A. Drusen as risk factors in age-related macular disease. Am J Ophthalmol 1990; 109: 38-43.
26. Macular Photocoagulation Study Group. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol 1997; 115(6): 741-747.
27. Mullins R, Anderson D, Russell S, Hageman G. Ocular drusen contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 2000; 14: 835-846.
28. Johnson L, Ozaki S, Staples M, Erickson P, Anderson D. A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res 2000; 70: 441-449.
29. Hageman G, Anderson D, Johnson L, Hancox L, Taiber A, Hardisty L et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005; 102: 7227-7232.
30. Penfold P, Killingsworth M, Sarks S. An ultrastructural study of the role of leucocytes and fibroblasts in the breakdown of Bruch's membrane. Aust J Ophthalmol 1984; 12: 23-31.
31. Penfold P, Provis J, Billson F. Age-related macular degeneration: ultrastructural studies of the relationship of leukocytes to angiogenesis. Graefes Arch Clin Exp Ophthalmol 1987; 225: 70-76.
32. Penfold P, Killingsworth M, Sarks S. Senile macular degeneration: the involvement of immunocompetent cells. Graefes Arch Clin Exp Ophthalmol 1985; 223: 69-76.
33. Lopez P, Grossniklaus H, Lambert H, Aaberg T, Capone A, Sternberg P et al. Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am J Ophthalmol 1991; 112: 647-656.
34. Grossniklaus H, Green W, Submacular Surgery Trials Research Group. Histopathologic and ultrastructural findings of surgically excised choroidal neovascularization. Arch Ophthalmol 1998; 116: 745-749.
35. Grossniklaus H, Cingle K, Yoon Y, Ketkar N, L'Hernault N, Brown S. Correlation of histologic 2-dimensional reconstruction and confocal scanning laser microscopic imaging of choroidal neovascularization in eyes with agerelated maculopathy. Arch Ophthalmol 2000; 118: 625-629.
36. Grossniklaus HE, Ling JX, Wallace TM, Dithmar S, Lawson DH, Cohen C et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis 2002; 8: 119-126.
37. Hageman G, Luthert P, Chong N, Johnson L, Anderson D, Mullins R. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPEBruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 2001; 20: 705-732.
38. Hageman GS, Mullins RF. Association of major histocompatibility class II antigens with core subdomains present within human ocular drusen. In: Zierhut M, Rammensee H, Streilein WJ (eds). Antigen-presenting Cells and the Eye. Taylor & Francis Medical Books: London, 2007, pp 209-216.
39. Radi Z, Kehrli M, Ackermann M. Cell adhesion molecules, leukocyte trafficking, and strategies to reduce leukocyte infiltration. J Vet Intern Med 2001; 15: 516-529.
40. Mullins R, Skeie J, Malone E, Kuehn M. Macular and peripheral distribution of ICAM-1 in the human choriocapillaris and retina. Mol Vis 2006; 12: 224-235.
41. Grunwald J, Metelitsina T, Dupont J, Ying G, Maguire M. Reduced foveolar choroidal blood flow in eyes with increasing AMD severity. Invest Ophthalmol Vis Sci 2005; 46: 1033-1038.
42. Szekanecz Z, Koch A. Macrophages and their products in rheumatoid arthritis. Curr Opin Rheumatol 2006; 19: 289-295.
43. Gasque P. Complement: a unique innate immune sensor for danger signals. Mol Immunol 2004; 41: 1089-1098.
44. Reinders M, Sho M, Izawa A, Wang P, Mukhopadhyay D, Koss K et al. Proinflammatory functions of vascular endothelial growth factor in alloimmunity. J Clin Invest 2003; 112: 1655-1665.
45. Zittermann S, Issekutz A. Endothelial growth factors VEGF and bFGF differentially enhance monocyte and neutrophil recruitment to inflammation. J Leukoc Biol 2006; 80: 247-257.
46. Sarks S. Ageing and degeneration in the macular region: a clinico-pathological study. Br J Ophthalmol 1976; 60(5): 324-341.
47. Green W, Enger C. Age-related macular degeneration histopathologic studies. Ophthalmology 1993; 100: 1519-1535.
48. Curcio C, Millican C. Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch Ophthalmol 1999; 117: 329-339.
49. Curcio C, Presley J, Malek G, Medeiros N, Avery D, Kruth H. Esterified and unesterified cholesterol in drusen and basal deposits of eyes with age-related maculopathy. Exp Eye Res 2005; 81: 731-741.
50. Sarks S, Cherepanoff S, Killingsworth M, Sarks J. Relationship of Basal laminar deposit and membranous debris to the clinical presentation of early age-related macular degeneration. Invest Ophthalmol Vis Sci 2007; 48: 968-977.
51. Duvall J, Tso M. Cellular mechanisms of resolution of drusen after laser coagulation: an experimental study. Arch Ophthalmol 1985; 103: 694-703.
52. Forrester J. Macrophages eyed in macular degeneration. Nat Med 2003; 9: 1350-1351.
53. Charo I, Taubman M. Chemokines in the pathogenesis of vascular disease. Circ Res 2004; 95: 858-866.
54. Ambati J, Anand A, Fernandez S, Sakurai E, Lynn B, Kuziel W et al. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med 2003; 9(11): 1390-1397.
55. Tuo J, Bojanowski C, Zhou M, Shen D, Ross R, Rosenberg K et al. Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. Invest Ophthalmol Vis Sci 2007; 48: 3827-3836.
56. Handa J, Verzijl N, Matsunaga H, Aotaki-Keen A, Lutty G, te Koppele J et al. Increase in the advanced glycation end product pentosidine in Bruch's membrane with age. Invest Ophthalmol Vis Sci 1999; 40(3): 775-779.
57. Ishibashi T, Murata T, Hangai M, Nagai R, Horiuchi S, Lopez P et al. Advanced glycation end products in agerelated macular degeneration. Arch Ophthalmol 1998; 116: 1629-1632.
58. Ma W, Lee S, Guo J, Qu W, Hudson B, Schmidt A et al. RAGE ligand upregulation of VEGF secretion in ARPE-19 cells. Invest Ophthalmol Vis Sci 2007; 48: 1355-1361.
59. el Khoury J, Thomas C, Loike J, Hickman S, Cao L, Silverstein S. Macrophages adhere to glucose-modified basement membrane collagen IV via their scavenger receptors. J Biol Chem 1994; 269: 10197-10200.
60. Ohgami N, Nagai R, Ikemoto M, Arai H, Kuniyasu A, Horiuchi S et al. CD36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products. J Biol Chem 2001; 276: 3195-3202.
61. Fadok V, Bratton D, Konowal A, Freed P, Westcott J, Henson P. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998; 101: 890-898.
62. Ryan S. Subretinal neovascularization after argon laser photocoagulation. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1980; 215(1): 29-42.
63. Tobe T, Okamoto N, Vinores M, Derevjanik N, Vinores S, Zack D et al. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Invest Ophthalmol Vis Sci 1998; 39: 180-188.
64. Espinosa-Heidman D, Suner I, Hernandez E, Monroy D, Csaky K, Cousins S. Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2003; 44(8): 3586-3592.
65. Biewenga J, van der Ende M, Krist L, Borst A, Ghufron M, van Rooijen N. Macrophage depletion in the rat after intraperitoneal administration of liposome-encapsulated clodronate: depletion kinetics and accelerated repopulation of peritoneal and omental macrophages by administration of Freund's adjuvant. Cell Tissue Res 1995; 280: 189-196.
66. Sakurai E, Anand A, Ambati B, van Rooijen N, Ambati J. Macrophage depeletion inhibits experimental chorodial neovascularization. Invest Ophthalmol Vis Sci 2003; 44(8): 3578-3585.
67. Tsutsumi C, Sonoda KH, Egashira K, Qiao H, Hisatomi T, Nakao S et al. The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization. J Leukoc Biol 2003; 74(1): 25-32.
68. Sakurai E, Taguchi H, Anand A, Ambati B, Gragoudas E, Miller J et al. Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci 2003; 44: 2743-2749.
69. Tsutsumi-Miyahara C, Sonoda K, Egashira K, Ishibashi M, Qiao H, Oshima T et al. The relative contributions of each subset of ocular infiltrated cells in experimental choroidal neovascularisation. Br J Ophthalmol 2004; 88(9): 1217-1222.
70. Zhou J, Pham L, Zhang N, He S, Gamulescu M, Spee C et al. Neutrophils promote experimental choroidal neovascularization. Mol Vis 2005; 11: 414-424.
71. Apte RS, Richter J, Herndon J, Ferguson TA. Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med 2006; 3(8): e310.
72. Espinosa-Heidmann DG, Suner IJ, Catanuto P, Hernandez EP, Marin-Castano ME, Cousins SW. Cigarette smokerelated oxidants and the development of sub-RPE deposits in an experimental animal model of dry AMD. Invest Ophthalmol Vis Sci 2006; 47(2): 729-737.
73. Mocellin S, Marincola F, Rossi C, Nitti D, Lise M. The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle. Cytokine Growth Factor Rev 2004; 15: 61-76.
74. Vora M, Romero L, Karasek M. Interleukin-10 induces E-selectin on small and large blood vessel endothelial cells. J Exp Med 1996; 184: 821-829.
75. Li B, Nayini J, Sivaraman S, Song S, Larson A, Toofanfard M et al. In vivo effects of IL-4, IL-10, and amifostine on cytokine production in patients with acute myelogenous leukemia. Leuk Lymphoma 2001; 41: 1661-1668.
76. Wangoo A, Laban C, Cook H, Glenville B, Shaw R. Interleukin-10- and corticosteroid-induced reduction in type I procollagen in a human ex vivo scar culture. Int J Exp Pathol 1997; 78: 33-41.
77. Lightman S, Calder V. Is IL-10 a good target to inhibit choroidal neovascularisation in age-related macular disease?. PLoS Med 2006; 3(8): e364.
78. Newsome D, Hewitt A, Huh W, Robey P, Hassell J. Detection of specific extracellular matrix molecules in drusen, Bruch's membrane, and ciliary body. Am J Ophthalmol 1987; 104: 373-381.
79. Fukushima I, McLeod D, Lutty G. Intrachoroidal microvascular abnormality: a previously unrecognized form of choroidal neovascularization. Am J Ophthalmol 1997; 124(4): 473-487.
80. Schwesinger C, Yee C, Rohan R. Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. Am J Pathol 2001; 158: 1161-1172.
81. Imamura Y, Noda S, Hashizume K, Shinoda K, Yamaguchi M, Uchiyama S et al. Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc Natl Acad Sci USA 2006; 103: 11282-11287.
82. Passlick B, Flieger D, Ziegler-Heitbrock H. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989; 74: 2527-2534.
83. Geissmann F, Jung S, Littman D. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003; 19: 71-82.
84. Gordon S, Taylor P. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5: 953-964.
85. Mullins R, Grassi M, Skeie J. Glycoconjugates of choroidal neovascular membranes in age-related macular degeneration. Mol Vis 2005; 11: 509-517.